Stock listing

IBX Stock Price, News, Filings & Events — Imagion Biosystems Ltd.

Selected listing: IBX · ASX · AUD · AU

This page tracks Imagion Biosystems Ltd.'s IBX:ASX listing on ASX in AUD for AU, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following IBX:ASX. IBX:ASX is the stock-level entry point for investors researching Imagion Biosystems Ltd., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Imagion Biosystems Ltd. (Ticker: IBX) is a public company based in Australia, focused on developing innovative medical imaging technologies. With a market capitalization of approximately AUD 4.89 million, the company aims to advance its proprietary imaging platform for improved healthcare outcomes.

IBX:ASXAUDAUUpdated September 4, 2026
Imagion Biosystems Ltd. logo
Ticker
IBX:ASX
Asset type
Stock
Market cap
$4.6M
Sector
Health Technology
Industry
Medical Specialties
Exchange
ASX
Currency
AUD

Imagion Biosystems Ltd. IBX:ASX stock context

This page tracks Imagion Biosystems Ltd.'s IBX:ASX listing on ASX in AUD for AU, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following IBX:ASX. IBX:ASX is the stock-level entry point for investors researching Imagion Biosystems Ltd., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Imagion Biosystems Ltd. (Ticker: IBX) is a public company based in Australia, focused on developing innovative medical imaging technologies. With a market capitalization of approximately AUD 4.89 million, the company aims to advance its proprietary imaging platform for improved healthcare outcomes.

Latest news from Imagion Biosystems Ltd.

All Imagion Biosystems Ltd. news →

Research Imagion Biosystems Ltd.

Alternate listings